This Week in Cell

An international team led by investigators in Germany and the US describe the transcription factor binding-based scheme they established for evaluating loci linked to type 2 diabetes risk. In their Cell study, the researchers demonstrated that this integrative computational strategy — which takes into account transcription factor binding site phylogeny and conservation in multiple species — can track down type 2 diabetes-associated variants with mechanistic ties to the disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.